West Bengal, India

Uday Bandyopadhyay

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Council of Scientific and Industrial Research, University of Calcutta. Active years: 1998-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uday Bandyopadhyay. Retrieved from https://idiyas.com/inventor/uday-bandyopadhyay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Calcutta, IN (1998)
  • West Bengal, IN (2014)

Company Filing History:


Years Active: 1998-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Uday Bandyopadhyay in Gastropathy Research

Introduction

Uday Bandyopadhyay is an accomplished inventor based in West Bengal, India, known for his significant contributions to the field of medicinal chemistry. With a total of two patents to his name, he has focused his research on developing novel compounds that offer potential therapeutic benefits, particularly in the context of gastropathy.

Latest Patents

Bandyopadhyay's latest patents include groundbreaking work on "Tryptamine derivatives, their preparation and their use in gastropathy." This research emphasizes the synthesis and evaluation of different tryptamine derivatives which exhibit excellent antioxidant properties in vitro. Notably, the compound SEGA (3a), formed by the combination of serotonin with gallic acid, demonstrates superior antioxidant qualities compared to other synthesized compounds, both in vivo and in vitro. SEGA (3a) exhibits a gastroprotective effect against NSAIDs (indomethacin or diclofenac)-induced gastropathy in a dose-dependent manner, accelerating healing from injury and preventing mitochondrial oxidative stress induced by NSAIDs. Additionally, SEGA (3a) acts as an iron chelator and an intra-mitochondrial ROS scavenger, making it a potent antioxidant anti-apoptotic molecule capable of addressing NSAID-induced gastropathy and stress or alcohol-mediated gastric damage.

His second patent, focused on the "Process for the isolation of an active principle from Azadirachta indica," presents a new method for isolating a phenolic glycoside from neem bark aqueous extract. This phenolic glycoside has been shown to be highly effective in inhibiting gastric acid secretion, as well as preventing stress-induced gastric ulceration. The innovative process involves lyophilizing the aqueous extract and using a series of solvent extractions, culminating in HPLC techniques to isolate the active compound.

Career Highlights

Bandyopadhyay has contributed his expertise as part of respected institutions such as the Council of Scientific & Industrial Research and the University of Calcutta. His work in these organizations has facilitated significant advancements in medicinal research, particularly concerning gastrointestinal health.

Collaborations

Throughout his research career, Uday Bandyopadhyay has collaborated with fellow researchers, including Chinmay Pal and Samik Bindu. Their collective efforts have contributed to the successful development of innovative solutions aimed at mitigating gastrointestinal issues.

Conclusion

In summary, Uday Bandyopadhyay's innovative contributions to the field of gastropathy research highlight his role as a significant inventor. Through his patents, he has advanced the scientific understanding of medicinal compounds and their applications in treating gastrointestinal disorders, establishing a foundation for future research and development in this critical area of health science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…